Kraj: Nowa Zelandia
Język: angielski
Źródło: Medsafe (Medicines Safety Authority)
Carbetocin 100ug; Carbetocin 100 µg/mL
Pharmaco (NZ) Ltd
Carbetocin 100 µg
100 mcg
Solution for injection
Active: Carbetocin 100ug Excipient: Glacial acetic acid Sodium chloride Water for injection Active: Carbetocin 100 µg/mL Excipient: Mannitol Methionine Sodium hydroxide Succinic acid Water for injection
Ampoule, glass, 5 x 1mL ampoules, 5 dose units
Prescription
Prescription
Polypeptide Laboratories France SAS
DURATOCIN is indicated for the prevention of uterine atony and excessive bleeding following delivery of the infant by elective caesarean section under epidural or spinal anaesthesia.
Package - Contents - Shelf Life: Vial, glass, Type I clear with bromobutyl rubber stopper and aluminium crimp cap with tear-off over cap - 5 dose units - 36 months from date of manufacture stored at or below 30°C
2003-02-17
________________________________________________________________________________ DURATOCIN ® 1 DURATOCIN INJECTION _Carbetocin_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Duratocin. It does not contain all the available information. It does not take the place of talking to your doctor. All medicines have risks and benefits . Your doctor has weighed the risks of you having Duratocin against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR. KEEP THIS LEAFLET You may need to read it again. WHAT DURATOCIN IS USED FOR Duratocin contains carbetocin, a substance which is an oxytocic agent and causes the womb (uterus) to contract. Duratocin is used to minimise post delivery bleeding in women who have delivered their baby by elective caesarean section under local anaesthetic around the spinal cord (epidural). _HOW IT WORKS_ In some women, following delivery by caesarean section, the womb fails to contract quickly enough which increases the risk of bleeding. Drugs that act directly on the womb to make it contract are used to minimise post delivery bleeding and are sometimes called oxytocic agents because they act in a similar manner to oxytocin. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU . Your doctor may have prescribed it for another reason. Duratocin is available only with a doctor’s prescription. It is not addictive. BEFORE YOU ARE GIVEN DURATOCIN _WHEN YOU MUST NOT BE_ _GIVEN IT_ DURATOCIN MUST NOT BE GIVEN IF YOU HAVE AN ALLERGY TO: carbetocin, the active ingredient, or to any of the ingredients listed at the end of this leaflet any medicines containing oxytocin. Symptoms of an allergic reaction may include: Przeczytaj cały dokument
DURATOCIN Carbetocin Injection PRESENTATION Each ampoule contains 100µg of carbetocin, 9mg sodium chloride, acetic acid - glacial to pH 3.8 and water for injections to 1mL. DURATOCIN is a ready-for-use clear, colourless solution for injection containing 100µg carbetocin in a 1mL clear glass ampoule with a white identification ring and a blue dot indicating the cut area. USES ACTIONS DURATOCIN (carbetocin injection) is a long-acting synthetic octapeptide analogue of oxytocin with agonist properties. It can be administered intravenously as a single dose immediately following delivery by caesarean section under epidural or spinal anaesthesia, to prevent uterine atony and postpartum haemorrhage. The clinical and pharmacological properties of carbetocin are similar to those of naturally occurring oxytocin, another posterior pituitary hormone. In _in vitro _studies, carbetocin was shown to bind to the oxytocin receptor with similar affinity as the natural peptide. Carbetocin elicited similar uteronic and galactogogic effects to oxytocin in animals and _in vitro_. Carbetocin was less potent than oxytocin, but its action was more prolonged. The oxytocin receptor content of the uterus is very low in the non-pregnant state, and increases during pregnancy, reaching a peak at the time of delivery. Therefore carbetocin has no effect on the non-pregnant uterus, and has a potent uterotonic effect on the pregnant and immediate postpartum uterus. The onset of uterine contraction following carbetocin administration by either the intravenous or intramuscular route is rapid, with a firm contraction being obtained within 2 minutes in around 90% of patients. The total duration of action of a single intravenous injection of carbetocin on uterine activity is about one hour suggesting that carbetocin Przeczytaj cały dokument